Characterizing α-Tropomyosin Mutations in Engineered Heart Tissue (Sanjana Nistala) and AI for the pharmacological targeting of protein folding metastable states (Alan Ianeselli)

Sanjana Nistala (Campbell Lab): Characterizing α-Tropomyosin Mutations in Engineered Heart Tissue, and Alan Ianeselli (Gerstein Lab): AI for the pharmacological targeting of protein folding metastable states.